ALNY - Alnylam Pharmaceuticals' (ALNY) CEO Yvonne Greenstreet on Q4 2021 Results - Earnings Call Transcript

Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2021 Earnings Conference Call February 10, 2022 8:30 AM ET Company Participants Christine Lindenboom – Senior Vice President of Investor Relations and Corporate Communications Yvonne Greenstreet – Chief Executive Officer Tolga Tanguler – Chief Commercial Officer Akshay Vaishnaw – President Jeff Poulton – Chief Financial Officer Conference Call Participants Ritu Baral – Cowen Gena Wang – Barclays Tazeen Ahmad – Bank of America Paul Matteis – Stifel Alethia Young – Cantor Fitzgerald Anupam Rama – JPMorgan Salveen Richter – Goldman Sachs Maury Raycroft – Jefferies Presentation Operator Good day, and thank you for standing by. Welcome to the Alnylam Pharmaceuticals Fourth Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised today’s conference may be recorded. [Operator Instructions] I’d now like to hand the conference over

For further details see:

Alnylam Pharmaceuticals' (ALNY) CEO Yvonne Greenstreet on Q4 2021 Results - Earnings Call Transcript